Synopsis
Synopsis
0
CEP/COS
0
VMF
0
FDF
0
Australia
0
South Africa
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 863031-24-7
2. Azilsartan (medoxomil Monopotassium)
3. Azilsartan Kamedoxomil
4. Azilsartan Medoxomil Monopotassium
5. Bcp11249
6. Sb19561
7. Hy-17458
8. Potassium;(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxo-1-oxa-4-aza-2-azanidacyclopent-3-en-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
9. Potassium 3-(4'-((2-ethoxy-7-(((5-methyl-2-oxo-1,3-dioxol-4-yl)methoxy)carbonyl)-1h-benzo[d]imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)-5-oxo-5h-1,2,4-oxadiazol-2-ide
Molecular Weight | 606.6 g/mol |
---|---|
Molecular Formula | C30H23KN4O8 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 10 |
Exact Mass | 606.11529519 g/mol |
Monoisotopic Mass | 606.11529519 g/mol |
Topological Polar Surface Area | 129 Ų |
Heavy Atom Count | 43 |
Formal Charge | 0 |
Complexity | 1110 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product ...
About the Company : Ami Lifesciences, established in 2006, is one of the fastest growing API manufacturing companies in India. Specializing in cardiovascular, anti-diabetic, CNS, and respiratory thera...
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
Jinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.
About the Company : Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our core services include c...
About the Company : Established in May 2012, Shandong Loncom Pharmaceutical operates as a fully owned subsidiary of Shandong Bestcomm Pharmaceutical Co., Ltd. Situated in the Qihe Economic Development...
About the Company : Back in the year 1973, a team of individuals came up with such an idea – The idea called Alkem. Looking back at our 5 decades, illustrious journey, that one small idea has Not on...
About the Company : Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company comme...
About the Company : Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has been founded since 2001 and occupied 100,000m2. Company has 80 million RMB reg...
About the Company : MAITHILI is a group of companies based in India (MAM, MLS, MAC, MAT,SGG) and Singapore(MITCO). Maithili Life Sciences (MLS) is a Contract Research Organization headquartered in Hy...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : RX
Registration Country : USA
Brand Name : EDARBI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 80MG MEDOXOMIL
Packaging :
Approval Date : 2011-02-25
Application Number : 200796
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Canada
AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM)
Brand Name : EDARBYCLOR
Dosage Form : TABLET
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number : 2397765
Regulatory Info :
Registration Country : Canada
Regulatory Info : DISCN
Registration Country : USA
Brand Name : AZILSARTAN MEDOXOMIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 40MG MEDOXOMIL
Packaging :
Approval Date : 2022-07-20
Application Number : 214489
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Uzbekistan
Brand Name : Azisar
Dosage Form : Tablet
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Uzbekistan
Regulatory Info :
Registration Country : Sweden
Brand Name : Edarbi
Dosage Form : TABLET
Dosage Strength : 80 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Ipreziv
Dosage Form : TABLET
Dosage Strength : 20 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Ipreziv
Dosage Form : TABLET
Dosage Strength : 40 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Switzerland
Brand Name : Edarbi
Dosage Form : Tablet
Dosage Strength : 20mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Edarbi
Dosage Form : Tablet
Dosage Strength : 40mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Azilsartanum medoxomilum; Chlortalidonum
Brand Name : Edarbyclor
Dosage Form : Filmtabl
Dosage Strength : 40/12.5mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
RLD : Yes
TE Code :
Brand Name : EDARBI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 40MG MEDOXOMIL
Approval Date : 2011-02-25
Application Number : 200796
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : EDARBI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 80MG MEDOXOMIL
Approval Date : 2011-02-25
Application Number : 200796
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE
Brand Name : EDARBYCLOR
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 40MG MEDOXOMIL;12.5MG
Approval Date : 2011-12-20
Application Number : 202331
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE
Brand Name : EDARBYCLOR
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 40MG MEDOXOMIL;25MG
Approval Date : 2011-12-20
Application Number : 202331
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : No
TE Code :
Brand Name : AZILSARTAN MEDOXOMIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 40MG MEDOXOMIL
Approval Date : 2022-07-20
Application Number : 214489
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : AZILSARTAN MEDOXOMIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 80MG MEDOXOMIL
Approval Date : 2022-07-20
Application Number : 214489
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Regulatory Info :
Registration Country : Sweden
Brand Name : Edarbi
Dosage Form : TABLET
Dosage Strength : 80 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Edarbi
Dosage Form : TABLET
Dosage Strength : 20 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Ipreziv
Dosage Form : TABLET
Dosage Strength : 20 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Ipreziv
Dosage Form : TABLET
Dosage Strength : 80 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Ipreziv
Dosage Form : TABLET
Dosage Strength : 40 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Switzerland
Brand Name : Edarbi
Dosage Form : Tablet
Dosage Strength : 40mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Edarbi
Dosage Form : Tablet
Dosage Strength : 40mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Edarbi
Dosage Form : Tablet
Dosage Strength : 80mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Azilsartanum medoxomilum; Chlortalidonum
Brand Name : Edarbyclor
Dosage Form : Filmtabl
Dosage Strength : 40/12.5mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Azilsartanum medoxomilum; Chlortalidonum
Brand Name : Edarbyclor
Dosage Form : Filmtabl
Dosage Strength : 40/12.5mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Azilsartan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Azilsartan, including repackagers and relabelers. The FDA regulates Azilsartan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Azilsartan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Azilsartan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Azilsartan supplier is an individual or a company that provides Azilsartan active pharmaceutical ingredient (API) or Azilsartan finished formulations upon request. The Azilsartan suppliers may include Azilsartan API manufacturers, exporters, distributors and traders.
click here to find a list of Azilsartan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Azilsartan DMF (Drug Master File) is a document detailing the whole manufacturing process of Azilsartan active pharmaceutical ingredient (API) in detail. Different forms of Azilsartan DMFs exist exist since differing nations have different regulations, such as Azilsartan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Azilsartan DMF submitted to regulatory agencies in the US is known as a USDMF. Azilsartan USDMF includes data on Azilsartan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Azilsartan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Azilsartan suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Azilsartan Drug Master File in Japan (Azilsartan JDMF) empowers Azilsartan API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Azilsartan JDMF during the approval evaluation for pharmaceutical products. At the time of Azilsartan JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Azilsartan suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Azilsartan Drug Master File in Korea (Azilsartan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Azilsartan. The MFDS reviews the Azilsartan KDMF as part of the drug registration process and uses the information provided in the Azilsartan KDMF to evaluate the safety and efficacy of the drug.
After submitting a Azilsartan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Azilsartan API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Azilsartan suppliers with KDMF on PharmaCompass.
A Azilsartan written confirmation (Azilsartan WC) is an official document issued by a regulatory agency to a Azilsartan manufacturer, verifying that the manufacturing facility of a Azilsartan active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Azilsartan APIs or Azilsartan finished pharmaceutical products to another nation, regulatory agencies frequently require a Azilsartan WC (written confirmation) as part of the regulatory process.
click here to find a list of Azilsartan suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Azilsartan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Azilsartan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Azilsartan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Azilsartan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Azilsartan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Azilsartan suppliers with NDC on PharmaCompass.
Azilsartan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Azilsartan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Azilsartan GMP manufacturer or Azilsartan GMP API supplier for your needs.
A Azilsartan CoA (Certificate of Analysis) is a formal document that attests to Azilsartan's compliance with Azilsartan specifications and serves as a tool for batch-level quality control.
Azilsartan CoA mostly includes findings from lab analyses of a specific batch. For each Azilsartan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Azilsartan may be tested according to a variety of international standards, such as European Pharmacopoeia (Azilsartan EP), Azilsartan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Azilsartan USP).
LOOKING FOR A SUPPLIER?